Personalized macrophage cell therapy (Proneuron)

N/A

Report date: 2022/11/25 17:30:01

Base Information

Drug NamePersonalized macrophage cell therapy (Proneuron)

Drug Alias NameAutologous incubated macrophage therapyProCord

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIsrael

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesProneuron Biotechnologies Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesProneuron Biotechnologies Inc

Active IndicationsN/A

Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A